N-[5-[1-[4-chloro-3-(trifluoromethyl)phenyl]ethylcarbamoylamino]-2-pyridinyl]-1,3-thiazole-4-carboxamide
C19H15ClF3N5O2S — CID 141025171
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-[1-[4-chloro-3-(trifluoromethyl)phenyl]ethylcarbamoylamino]-2-pyridinyl]-1,3-thiazole-4-carboxamide
N-[5-[1-[4-chloro-3-(trifluoromethyl)phenyl]ethylcarbamoylamino]-2-pyridinyl]-1,3-thiazole-4-carboxamide (PubChem CID 141025171) has the molecular formula C19H15ClF3N5O2S and a molecular weight of 469.88 g/mol. Its IUPAC name is N-[5-[1-[4-chloro-3-(trifluoromethyl)phenyl]ethylcarbamoylamino]-2-pyridinyl]-1,3-thiazole-4-carboxamide.
Molecular Properties
| Compound Name | N-[5-[1-[4-chloro-3-(trifluoromethyl)phenyl]ethylcarbamoylamino]-2-pyridinyl]-1,3-thiazole-4-carboxamide |
|---|---|
| PubChem CID | 141025171 |
| Molecular Formula | C19H15ClF3N5O2S |
| Molecular Weight | 469.88 g/mol |
| Exact Mass | 469.06 |
| IUPAC Name | N-[5-[1-[4-chloro-3-(trifluoromethyl)phenyl]ethylcarbamoylamino]-2-pyridinyl]-1,3-thiazole-4-carboxamide |
| SMILES | CC(NC(=O)Nc1ccc(NC(=O)c2cscn2)nc1)c1ccc(Cl)c(C(F)(F)F)c1 |
| InChI | InChI=1S/C19H15ClF3N5O2S/c1-10(11-2-4-14(20)13(6-11)19(21,22)23)26-18(30)27-12-3-5-16(24-7-12)28-17(29)15-8-31-9-25-15/h2-10H,1H3,(H,24,28,29)(H2,26,27,30) |
| InChIKey | MKTDJXPFBYLMTN-UHFFFAOYSA-N |
| XLogP | 5.35 |
| TPSA | 96.01 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 469.88 |
| LogP ≤ 5 | 5.35 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 141025171 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.